Top

Cardiovascular Intervention and Therapeutics

Published in:

01-07-2015 | Case Report

Contrast stainings outside the stents of the superficial femoral artery after polymer-free drug-eluting peripheral stents implantation

Authors: Akihiro Nakamura, Kazuki Noda, Sota Nakajima, Hideaki Endo, Tohru Takahashi, Eiji Nozaki

Published in: Cardiovascular Intervention and Therapeutics | Issue 3/2015

Abstract

A 65-year-old man with occlusion of the left superficial femoral artery (SFA) underwent the endovascular therapy (EVT). A successful EVT was performed with three paclitaxel-eluting peripheral stents (Zilver PTX^®) implanted in the left SFA. Angiography 1 year later showed an exudation of contrast outside the stent struts, and intravascular ultrasound, and optical coherence tomography also showed incomplete stent apposition with remarkable positive vascular remodeling. Zilver PTX^® stent is a polymer-free stent and it is unclear that the reason why the patient treated with Zilver PTX^® stents in the SFA lesions caused the contrast stainings outside the stents. However, we need more careful long-term follow-up of this patient for late thrombosis.

Soga Y, Tomoi Y, Sato K, Iida O, Tokoi H. Clinical outcome after endovascular treatment for isolated common femoral and opoliteal artery disease. Cardiovasc Interv Ther. 2013;28(3):250–7.PubMedCrossRef

Dohi T, Iida O, Okamoto S, Nanto K, Nanto S, Uematsu M. Mid-term clinical outcome following endovascular therapy in patients with chronic aortic occlusion. Cardiovasc Interv Ther. 2013;28(4):327–32.PubMedCrossRef

Sakamoto Y, Hirano K, Iida O, Suzuki Y, Muramatsu T, Tsukahara R. Five-year outcomes of self-expanding nitinol stent implantation for chronic total occlusion of the superficial femoral and proximal popliteal artery. Cardiovasc Interv Ther. 2013;82(3):E251–6 (Epub ahead of print).CrossRef

Bosiers M, Deloose K, Keirse K, Verbist J, Peeters P. J Cardiovasc Surg (Torino). 2010;51(1):115–9.PubMed

Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, et al. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613–23.PubMedCrossRef

Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB, et al. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv. 2011;4:495–504.PubMedCrossRef

Kon H, Sakai H, Otsubo M, Takano H, Okamoto K, Sato T, et al. Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. Circ Cardiovasc Interv. 2011;4(1):e1–3.PubMedCrossRef

Imai M, Kadota K, Goto T, Fujii S, Yamamoto H, Fuku Y, et al. Incidence, risk factors, and clinical sequelae of angiographic peri-stent contrast staining after sirolimus-eluting stent implantation. Circulation. 2011;123:2382–91.PubMedCrossRef

Mintz GS. What to do about late incomplete stent apposition? Circulation. 2007;115:2379–81.PubMedCrossRef

10.

Kume T, Waseda K, Ako J, Sakata K, Yamasaki M, Shimohama T, et al. Intravascular ultrasound assessment of post procedural incomplete stent apposition. J Invasive Cardiol. 2012;24:13–6.PubMed

11.

Vivek M, Shah MS, Gary S, Mintz MD, Sue Apple DNSc, Neil J, et al. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 2002;106:1753–5.CrossRef

12.

Attizzani GF, Capodanno D, Ohno Y, Tamburino C. Mechanisms, pathophysiology, and clinical aspects of incomplete stent apposition. J Am Coll Cardiol. 2014;63:1355–67.PubMedCrossRef

13.

Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautions? Circulation. 2004;109:701–5.PubMedCrossRef

14.

Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202.PubMedCrossRef

15.

Lanjewar CP, Sharma A, Sheth T. IVUS-guided management of late stent malapposition with peri-stent restenosis with coronary artery aneurysm. J Invasive Cardiol. 2009;21:E87–90.PubMed

16.

Aoki J, Colombo A, Dudek D, Banning AP, Drzewiecki J, Zmudka K, et al. Peristent remodeling and neointimal suppression 2 years after polymer-based, paclitaxel-eluting stent implantation. Insight from serial intravascular ultrasound analysis in the TAXUS II study. Circulation. 2005;112:3876–83.PubMedCrossRef

17.

Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426–34.PubMedCrossRef

18.

Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414–9.PubMedCrossRef

Title: Contrast stainings outside the stents of the superficial femoral artery after polymer-free drug-eluting peripheral stents implantation
Authors: Akihiro Nakamura
Kazuki Noda
Sota Nakajima
Hideaki Endo
Tohru Takahashi
Eiji Nozaki
Publication date: 01-07-2015
Publisher: Springer Japan
Published in: Cardiovascular Intervention and Therapeutics / Issue 3/2015
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI: https://doi.org/10.1007/s12928-014-0290-4

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Contrast stainings outside the stents of the superficial femoral artery after polymer-free drug-eluting peripheral stents implantation

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2015

Transcatheter closure of a pulmonary arteriovenous malformation in a patient with hereditary hemorrhagic telangiectasia

A novel equitation to predict the pressure derived collateral flow index in multiple sequential coronary stenoses

Potential influence of invisible coronary collateral circulation on fractional flow reserve of donor artery in the presence of severe stenosis of receiving artery

Midterm outcomes of bare-metal stenting after primary stenting for ST-segment elevated myocardial infarctions in the drug-eluting stent era: a propensity score-matched comparison with sirolimus-eluting stent

Pre-procedural combined coronary angiography and stress myocardial perfusion imaging using 320-detector CT in unprotected left main and ostial left anterior descending artery intervention

Primary percutaneous coronary intervention and bleeding risk in the era of drug-eluting stent: a long-term cohort study

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page